N. Morelli (Den Haag, Netherlands), I. Bonovolias (Thessaloniki, Greece), L. Degani-Costa (São Paulo (SP), Brazil), M. Tamm (Basel, Switzerland)
Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
F. Di Marco (Milan, Italy), L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), F. Blasi (Milan, Italy), S. Centanni (Milan, Italy), C. Micheletto (Verona, Italy), A. Rossi (Verona, Italy), M. Cazzola (Rome, Italy)
|  |
Pseudomonas eradication management in COPD: results from a single centre
C. Wigston (Oxford, United Kingdom), M. Rana (Oxford, United Kingdom), H. Chreif (Oxford, United Kingdom), K. Jeffery (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
| |
Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
J. Minov (Skopje, FYROM (Macedonia)), J. Karadzinska-Bislimovska (Skopje, FYROM (Macedonia)), T. Petrova (Chicago, United States of America), K. Vasilevska (Skopje, FYROM (Macedonia)), S. Stoleski (Skopje, FYROM (Macedonia)), D. Mijakoski (Skopje, FYROM (Macedonia))
|  |
Risk of pneumonia and exacerbations of chronic obstructive pulmonary disease(COPD) with inhaled corticosteroid (ICS) use: a Singapore perspective
K. Koh (Singapore, Singapore), P. Tiew (Singapore, Singapore), J. Tan (Singapore, Singapore), R. Soh (Singapore, Singapore), K. Tan (Singapore, Singapore), T. Ong (Singapore, Singapore), M. Koh (Singapore, Singapore), S. Chotirmall (Singapore, Singapore), T. Lapperre (Singapore, Singapore)
| |
Long-term use of inhaled glucocorticoids in stable chronic obstructive pulmonary disease patients and risk of diabetes mellitus: systematic review of the literature
F. Arpinelli (Verona, Italy), P. Ruggeri (Messina, Italy), G. Girbino (Messina, Italy), G. Caramori (Messina, Italy)
| |
Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
S. Paul (Preston, United Kingdom), N. Koko (Preston, United Kingdom), P. Marsden (Preston, United Kingdom)
| |
Investigation of breathing parameters of COPD patients inhaling through three different DPI devices
A. Szipocs (Gyor, Hungary), Á. Farkas (Budapest, Hungary), J. Varga (Budapest, Hungary), Z. Szalai (Gyor, Hungary)
| |
The effect preoperative intervention with long-acting bronchodilator for untreated patients with obstructive lung disease
Y. Mikami (Tokyo, Japan), T. Jo (Tokyo, Japan), H. Matsuzaki (Tokyo, Japan), K. Hosoki (Tokyo, Japan), M. Saito (Tokyo, Japan), T. Ishimori (Tokyo, Japan), Y. Yamauchi (Tokyo, Japan), Y. Yatomi (Tokyo, Japan), D. Takai (Tokyo, Japan), T. Nagase (Tokyo, Japan)
| |
Short-acting bronchodilators for in-hospital management of acute exacerbation of COPD: Systematic Review
Z. Kopsaftis (South Australia, Australia), N. Sulaiman (South Australia, Australia), K. Carson (South Australia, Australia), O. Mountain (South Australia, Australia), P. Phillips (South Australia, Australia), B. Smith (South Australia, Australia)
| |
Efficacy and safety of budesonide/formoterol fumarate dihydrate metered dose inhaler (BFF MDI) using co-suspension delivery technology compared to monocomponents and an active comparator in COPD
G. Ferguson (Farmington Hills, United States of America), A. Papi (Ferrara, Italy), A. Anzueto (San Antonio, United States of America), E. Kerwin (Medford, United States of America), C. Cappelletti (Durham, United States of America), E. Duncan (Durham, United States of America), J. Nyberg (Morristown, United States of America), P. Dorinsky (Durham, United States of America)
| |
Effect of erdosteine in moderately severe COPD patients
P. Calverley (Aintree, United Kingdom), C. Page (London, United Kingdom), R. Dal Negro (Verona, Italy), G. Fontana (Firenze, Italy), M. Iversen (Copenhagen, Denmark), A. Cicero (Bologna, Italy), E. Pozzi (Paderno Dugnano, Italy), J. Wedzicha (London, United Kingdom)
| |
Observational study of adherence to indacaterol/glycopyrronium 110/50µg o.d. (IND/GLY) in COPD
N. Roche (Paris, France), V. Le Gros (Rueil Malmaison, France), M. Pouriel (Paris, France), L. Decuypere (Rueil Malmaison, France), C. Raherison (Bordeaux, France)
| |
Multiple ascending inhaled doses of AZD8871 in healthy males
V. Balaguer Sole (Barcelona, Spain), M. Albayaty (London, United Kingdom), C. Astbury (Barcelona, Spain), L. Jimenez (Barcelona, Spain), U. Wahlby Hamren (Gothenburg, Sweden), B. Seoane (Barcelona, Spain), M. Malice (Barcelona, Spain), A. Lei (Barcelona, Spain), A. Aggarwal (Boston, United States of America), I. Psallidas (Gothenburg, Sweden), A. Mailleux (arnaud.mailleux@inserm.fr / INSERM U1152,Paris)
| |
Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
I. Kharchenko (Kharkiv, Ukraine), O. Krakhmalova (Kharkiv, Ukraine), A. Tokarieva (Kharkiv, Ukraine)
| |
Switch from LABA+ICS to a LABA/LAMA combination in symptomatic women with COPD – an analysis of the observational DACCORD study
P. Kardos (Frankfurt, Germany), R. Buhl (Mainz, Germany), C. Criee (Bovenden , Germany), N. Lossi (Nuernberg, Germany), C. Vogelmeier (Marburg, Germany), H. Worth (Fuerth, Germany)
| |
Inhaled anticholinergics affect the heart rate recovery in stable COPD patients
W. Yuan (Beijing , China), S. Nie (Beijing , China), H. Wang (Beijing , China), Q. Xu (Beijing , China), N. Jia (Beijing , China)
| |
Effects of the long term treatment with Fenspiride upon clinical manifestations of chronic obstructive pulmonary disease
V. Calancea (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), E. Terna (Chisinau, Republic of Moldova), N. Bodrug (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova)
| |
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
S. Tanni (Botucatu, Brazil), B. Morais (Botucatu, Brazil), J. Zucchi (Botucatu, Brazil), E. Franco (Botucatu, Brazil), T. Santos (Botucatu, Brazil), T. Garcia (Botucatu, Brazil)
| |
Effect of benzodiazepines in hospital readmissions and mortality in patients with chronic obstructive pulmonary disease
J. Teran Tinedo (Madrid, Spain), D. López Padilla (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), W. Giron Matute (Madrid, Spain), L. Vicent Alaminos (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
| |
Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids
P. Sivapalan (Hellerup, Denmark), D. Bech Rasmussen (Odense, Denmark), T. Sylvan Ingebrigtsen (Hvidovre, Denmark), R. Sørensen (Copenhagen, Denmark), C. Bjørn Jensen (Copenhagen, Denmark), K. Højgaard Allin (Copenhagen, Denmark), F. Stæhr Holm (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), K. Armbruster (Hellerup, Denmark), J. Stæhr Jensen (Hellerup, Denmark)
| |